Zoetis Inc. ZTS
ZTS Rating
ZTS Rating Factors
ZTS Company Overview
Zoetis Inc. is a global animal health company focused on the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests, and precision animal health technologies for livestock and companion animals. The company operates within the broader animal health and veterinary pharmaceuticals industry and serves veterinarians, livestock producers, pet owners, and animal health distributors. Revenue is primarily generated through the sale of animal medicines and vaccines across therapeutic categories including anti-infectives, parasiticides, dermatology, pain management, reproductive products, and diagnostic solutions.
Zoetis traces its origins to Pfizer’s animal health division, which operated for decades before being spun off through an initial public offering in 2013. Since becoming an independent public company, Zoetis has expanded through internal research and targeted acquisitions, strengthening its position in companion animal therapeutics and diagnostics. The company is widely recognized for its scale, broad product portfolio, established veterinary relationships, and diversified exposure across species and geographies. Its strategic positioning is supported by extensive research and development capabilities, global manufacturing infrastructure, and a strong portfolio of established brands in both livestock and pet care markets.
ZTS Income Statement
ZTS Balance Sheet
ZTS Price History
ZTS Valuation
ZTS Dividends and Shares
ZTS Corporate Info
Parsippany, NJ 07054